Base Therapeutics

Private

ShanghaiHealthcare & Life Scienceshttps://www.basetherapeutics.com/

Last Round

Series A

Extension

Sep 12, 2024

Total Funding Raised

$34.5M

Company Overview

Base Therapeutics is a biotechnology company specializing in gene editing and cell-based therapies for the treatment of cancer and genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

base editinggene editingcell therapyprime editingCRISPR alternativeNK cell therapybiotech licensingprecision medicineoff-the-shelf therapygene therapynext-gen gene editingbiopharmaceutical partnershipGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Base Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Base Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Base Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Sep 12, 2024
Series A	Jan 18, 2023

View all Funding Rounds

Base Therapeutics Investors

Notable investors and investment history

Base Therapeutics investors
Investor	Rounds
HighLight Capital	Series A
Gobi Partners	Seed
Spark Ventures	Series A
Baidu Ventures	Series A
Gobi Partners GBA	Series A Extension

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 18, 2023
$20M round led by Great Eagle Holdings Limited.

View all signals

Base Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Base Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Base Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Year Founded2021

Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.